Immunohistochemical demonstration of cyclin D1 in bladder cancers as an inverse indicator of invasiveness but not an independent prognostic factor - Concepedia

Concepedia

Publication | Closed Access

Immunohistochemical demonstration of cyclin D1 in bladder cancers as an inverse indicator of invasiveness but not an independent prognostic factor

28

Citations

26

References

2000

Year

Yasuharu Takagi, Munehisa Takashi, Takashi Koshikawa, Takao Sakata, Shinichi Ohshima

International Journal of Urology

Abstract

These findings suggest that cyclin D1 demonstrated immunohistochemically could be used as an inverse indicator for the level of invasiveness of bladder cancer, but not as an independent prognostic factor.

References

	Year	Citations
Regression Models and Life-Tables D. R. Cox Journal of the Royal Statistical Society Series B (Statistical Methodology) Regression ModelsReliability EngineeringConditional LikelihoodEngineeringLife Prediction	1972	38.8K
Nonparametric Estimation from Incomplete Observations Edward L. Kaplan, Paul Meier Journal of the American Statistical Association EngineeringAgingLife PredictionRare Event EstimationMortality Rates	1958	38.7K
Evaluation of survival data and two new rank order statistics arising in its consideration. Nathan Mantel PubMed Prognostic EvaluationLongevitySurvival DataPrognosisRare Event Estimation	1966	7.6K
A novel cyclin encoded by a bcl1-linked candidate oncogene Toru Motokura, Theodora Bloom, Hyung Goo Kim, Nature Novel CyclinOncogenic AgentMolecular BiologyMolecular GeneticsCell Cycle	1991	1.3K
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Dawn E. Quelle, Richard A. Ashmun, Sheila Shurtleff, Genes & Development ImmunologyCell ProliferationCytoskeletonCell CycleMammalian D-type Cyclins	1993	1K
Two molecular pathways to transitional cell carcinoma of the bladder. Charles Spruck, Petra F. Ohneseit, Mirella Gonzalez‐Zulueta, PubMed Cancer PathologyPathologyCancer BiologyTumor BiologyCarcinoma	1994	605
Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease Progression A. S. Sarkis, Guido Dalbagni, C. Cordon‐Cardo, JNCI Journal of the National Cancer Institute	1993	536
PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Carol L. Rosenberg, Emily Wong, Elizabeth M. Petty, Proceedings of the National Academy of Sciences Hematological MalignancyTumor BiologyCandidate Bcl1 OncogeneLymphoid NeoplasiaCll Controls	1991	440
Amplification and expression of the human cyclin D gene in esophageal cancer. Wei Jiang, Scott M. Kahn, Naohiro Tomita, PubMed Tumor BiologyEsophageal CancerOncogenic AgentMedicineCancer Cell Biology	1992	410
Amplification and Overexpression of Cyclin D1 in Human Hepatocellular Carcinoma Yongjie Zhang, Wei Jiang, C.J. Chen, Biochemical and Biophysical Research Communications HepatologyCyclin D1Liver PhysiologyMedicinePathology	1993	236

Page 1